EverPoint Asset Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

EverPoint Asset Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.44M	Buy	+400,000	New	+$2.09M	0.05%	314

Other funds holding SGYP

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

EverPoint Asset Management's SGYP Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2016: 400,000 shares worth $2.44M. The stake represents 0.05% of the portfolio and ranks #314 among its holdings.

156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

EverPoint Asset Management held 400,000 shares of Synergy Pharmaceuticals, Inc Common Stock worth $2.44M as of Q4 2016.
Synergy Pharmaceuticals, Inc Common Stock was a new EverPoint Asset Management position in Q4 2016.
Synergy Pharmaceuticals, Inc Common Stock made up 0.05% of EverPoint Asset Management's portfolio in Q4 2016, its #314 holding.
156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.